Thu, January 12, 2012
Wed, January 11, 2012
Tue, January 10, 2012
Mon, January 9, 2012
Sun, January 8, 2012
Sat, January 7, 2012
Fri, January 6, 2012
Thu, January 5, 2012
Wed, January 4, 2012
Tue, January 3, 2012
Mon, January 2, 2012
Sat, December 31, 2011
Fri, December 30, 2011
Thu, December 29, 2011
Wed, December 28, 2011
Tue, December 27, 2011

MURRAY FRANK LLP Announces Investigation of Synovis Life Technologies, Inc.


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. estigation-of-synovis-life-technologies-inc.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

NEW YORK--([ ])--MURRAY FRANK LLP is investigating claims of breach of fiduciary duties by certain members of the board of directors of Synovis Life Technologies, Inc. (NASDAQ: SYNO) (aSynovisa or the aCompanya) in relation to the acquisition of the Company by Baxter International Inc. (aBaxtera).

On December 13, 2011, Synovis and Baxter announced that they had entered into a definitive agreement pursuant to which Synovis will be acquired by Baxter, in an all-cash transaction under which Synovis stockholders will receive $28.00 in exchange for each share of Synovis common stock owned, a total value of approximately $325 million.

The investigation focuses on whether certain members of the board of directors breached their fiduciary duties in connection with their efforts to sell Synovis to Baxter at an inadequate price through an unfair process which significantly undervalues the Company.

If you are a current investor in Synovis, who purchased SYNO shares before December 13, 2011, and you wish to discuss this investigation or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Bridget V. Hamill at (800) 497-8076 or (212) 682-1818, or by email at [ investigations@murrayfrank.com ].


Publication Contributing Sources